Spatiotemporal Degradation of a Specific Protein as a New Cancer Therapy

Reading time: 12 minutes Felicites Rapon Recently, chemically engineered molecules have been produced to incite the degradation of a given protein. These molecules are called PROTACs [1], which stands for PROteolysis-TArgeting Chimeras.  How does the degradation of a protein work? The degradation of a protein, also called proteolysis, is achieved by the mechanism of ubiquitination.... Continue Reading →

Tracing the Footsteps of Lung Cancer

Reading time: 4 minutes Aya Elmeligy Tumor heterogeneity and lung cancer progression Intratumor heterogeneity is a key concept in the evolution and progression of many tumors, including lung cancers. As a tumor grows, its DNA continually develops mutations to overcome the effects of therapies. The cells that acquire these mutations are known as a subclone.... Continue Reading →

Extracellular Vesicles in Cancer

Reading time: 5 minutes Charlotte Boyd Extracellular vesicles (EVs) are small bubbles which are released from the cell. Cells produce multiple types of EVs which are different sizes ranging from approximately 30 nanometres to 10,000 nanometres. A nanometre is 10 million times smaller than a centimeter. This means that EVs are tiny and not visible... Continue Reading →

Can Exercise Treat Cancer?

Reading time: 3 minutes Sydney Scatigno Why do people exercise? There are a number of reasons people choose to engage in physical activity like walking, running, lifting weights, or playing sports. The more obvious reasons can include losing weight, building muscle, or improving overall physical appearance, but can it help treat diseases like cancer? There... Continue Reading →

Collagen Can Fuel Cancer Growth

Reading time: 5 minutes Yonika Larasati Accumulating knowledge shows that cancer cells do not thrive in isolation. Just as seeds need suitable soil to flourish into plants, cancer cells might perish without an appropriate environment. This environment, known as the tumor microenvironment (TME), has become an emerging trait of cancer that can be a target... Continue Reading →

Recent Advances in mRNA-based Cancer Vaccines

Reading time: 4 minutes Indiwari Gopallawa After years of seminal research work, mRNA technology got its moment as a result of the Covid-19 pandemic. However, mRNA-based cancer vaccines remain a relatively new and untapped class of vaccines that show great potential. The enthusiasm for this novel technology has been increasing due to recently published experimental... Continue Reading →

Phototherapy and its potential in cancer treatment

Reading time: 5 minutes Muhammad Ayhan Murtaza The word phototherapy comes from two words, “photo” and “therapy” which, evidently so, means “medical treatment using light”. The word has its roots in the older Greek language, but much like this old language, cancer is by no means a newer predicament. In fact, it actually predates human... Continue Reading →

Complexities in Metastasis Research

Reading time: 4 minutes Megan Majocha Can you imagine trying to put together clear, acrylic puzzle pieces? It is difficult to put together all the unknowns without a picture. Metastasis research is similar -  trying to put the pieces together without knowing exactly how metastatic cells function in the human body. While cancer metastasis research... Continue Reading →

Cancer vs. Targeted Agents: A Molecular Arms Race

Reading time: 4 minutes Mia Hubert Chronic myelogenous leukemia (CML) is a slow-progressing disease resulting from an overproduction of blood cells originating from the bone marrow, known as myeloid cells. Before 2001, the standard of care included chemotherapy and bone marrow transplantation (BMT). Unfortunately, chemotherapeutic approaches were non-curative and BMT entailed a high-risk procedure with... Continue Reading →

Updates in Pediatric Cancer: What’s New?

Reading time: 3 minutes Susan Egbert Pediatric cancer is a broad term that refers to cancers originating in children younger than 18. There are different types of pediatric cancer, but they all fall into one of two categories: solid tumors and leukemia. Solid tumors are cancers arising from cells in the body's tissues. These tumors... Continue Reading →

Anti-Angiogenic Cancer Treatments

Reading time: 5 minutes Aya Elmeligy Angiogenesis is the formation of blood vessels within the body to provide oxygen and nutrients to tissues. Tumors will hijack this process to allow for continued growth and metastasis by forming their own vascular system. Microvessel density within a tumor is often used as a prognosis tool, as the... Continue Reading →

Tumor-on-a-chip: A Better Method for Drug Discovery?

Reading time: 7 minutes Nayela Chowdhury Conventional 2D and 3D models of cancer have widely been utilized in pre-clinical drug development; however, neither of the platforms mimics the dynamic interactions that occur in living tumors. In vivo studies (for example, in small animal models)  have been central in translational cancer research and have contributed largely... Continue Reading →

‘Ubiquitous’ Ubiquitination Pathway and Cancer

Reading time: 4 minutes Deepika Jayaprakash What is common to eukaryotic organisms like animals, plants, fungi, and unicellular organisms? Ubiquitous Ubiquitin!   Ubiquitin (ub) is a small protein found in all eukaryotes that when attached to its target protein can bring about a myriad of cellular processes. The first observed effect of ubiquitination was degradation of... Continue Reading →

Non-small cell lung cancer and immunotherapy

Reading time: 4 minutes Indiwari Gopallawa Cancer is the second leading cause of death after cardiovascular diseases in the United States and has a major impact on society. Lung cancer is the second most common cancer type and is associated with lower survival rates and higher cancer-related deaths, accounting for 25% of all cancer-related deaths... Continue Reading →

3D Screening of Compounds for Cancer Therapy

Reading time: 4 minutes Sydney Scatigno Over the last couple of decades, cancer research has made strides in improving the pre-clinical assessment of novel compounds. Compound screening, the process of assessing new compounds for efficacy, across various cell lines is an important step in finding the optimal drug candidate downstream in the drug development process.... Continue Reading →

Create a website or blog at WordPress.com

Up ↑